Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune -- Ignore unavailable to you. Want to Upgrade?

To: Bosco who wrote (214)	5/22/2000 3:09:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 416

I like MEDI and bot some today as the general market sell off filled the up gap created when MEDI announced the 3/1 split last week. Been reading their annual report and this is truly a stellar company from all i can see. MedImmune Shareholders Clear the Way for Three-for-One Stock Split GAITHERSBURG, Md., May 18, 2000 /PRNewswire via COMTEX/ -- MedImmune, Inc. (Nasdaq: MEDI) announced today that at its Annual Shareholders' Meeting, shareholders voted to increase the number of authorized shares of MedImmune common stock from 120 million to 320 million. This action was a prerequisite for the company's previously announced three-for-one stock split to proceed. MedImmune's three-for-one stock split will be paid in the form of a 200- percent stock dividend to all shareholders of record at the close of business on May 18, 2000. This stock dividend provides shareholders two additional shares for every share owned. Distribution of the new shares will occur on or about Friday, June 2, 2000. Shareholders who hold their stock in a brokerage account, will receive their new shares through their broker who will credit their account. Shareholders who maintain physical possession of their stock certificates will have their additional shares mailed to them. The company's stock will begin trading at the post-split price on Monday, June 5, 2000. Any shares traded between May 18 and June 5 will come with a "due-bill" entitling the buyer to two additional shares for each share purchased that will be distributed on or about June 7. As of March 31, 1999, MedImmune had approximately 70 million shares of common stock outstanding. Following the split, the company will have approximately 210 million shares outstanding.